Boilève, A., Thomas, L. and Lillo-Le Louët, A. (2020) 5-Fluorouracil-Induced Hyperammonaemic Encephalopathy: A French National Survey. European Journal of Cancer, 129, 32-40.
https://doi.org/10.1016/j.ejca.2020.01.019

has been cited by the following article:

• TITLE: 5-Fluorouracil-Induced Hyperammonemia Encephalopathy in a Patient with Gastric Cancer

  AUTHORS: Toky Rakotoarivo, Vonjy Andrianarison, Ny Ony Andrianandrasana, Malala Razakanaivo, Florine Rafaramino

  KEYWORDS: Encephalopathy, Gastric Cancer, Hyperammonemia, 5-Fluororuracil

  JOURNAL NAME: Journal of Cancer Therapy, Vol.14 No.2, February 28, 2023

  ABSTRACT: Chemotherapy with 5-fluorouracil (5 FU) has been widely used to treat advanced gastric cancer. Knowing the side effects is therefore important in order to better prevent them. Fluoropyrimidine-induced hyperammonemic encephalopathy is a rare complication and characterized neurological status with elevated ammonia level without radiological abnormalities. We report the first case of 5 FU-induced hyperammonemic encephalopathy in women patients on induction chemotherapy for gastric cancer in Madagascar. His ammonia level (NH3) was 102 μmol/l. The patient recovered from his confusional state after two days of treatment with hyperhydration and vitamin therapy.